Update on Clinical Trials in Belgium
12:00 ? 13:00 Registration and lunch / networking
13:00 ? 14:00 Update on Clinical Trials in Belgium
Duo presentation by:
Nathalie Lambot, Expert Public Health: Clinical Trials-Regulatory Affairs, Pharma.be
Stefaan Vancayzeele, CSO Novartis Pharma, Vice-president BeAPP
14:00 ? 14:30 Q&A
14:30 ? 15:30 BeAPP extra general assemblee meeting
All BeAPP members are kindly invited to discuss new BeAPP bylaws, as proposed by BeAPP Board.